Jennifer Evans Stacey's most recent trade in Context Therapeutics Inc was a trade of 123,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc | Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 123,500 | 123,500 | - | - | Stock Option (right to buy) | |
| Context Therapeutics Inc | Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Context Therapeutics Inc | Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Galera Therapeutics Inc | Jennifer Evans Stacey | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 135,000 | 135,000 | - | - | Stock Option (Right to Buy) | |
| Context Therapeutics Inc | Jennifer Evans Stacey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Galera Therapeutics Inc | Jennifer Evans Stacey | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |